|
Sign In to gain access to subscriptions and/or personal tools.
|
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients
P Ferrante
Laboratory of Biology, Don C. Gnocchi Foundation, IRCCS (Research Hospital), Milan, Italy, Institute of Medical Microbiology, University of Milan, IRCCS, Milan, Italy
E Omodeo-Zorini
Laboratory of Biology, Don C. Gnocchi Foundation, IRCCS (Research Hospital), Milan, Italy
R Caldarelli-Stefano
Laboratory of Biology, Don C. Gnocchi Foundation, IRCCS (Research Hospital), Milan, Italy
M Mediati
Laboratory of Biology, Don C. Gnocchi Foundation, IRCCS (Research Hospital), Milan, Italy
E Fainardi
Neurological Clinic, University of Ferrara, IRCCS, Milan, Italy
E Granieri
Neurological Clinic, University of Ferrara, IRCCS, Milan, Italy
D Caputo
Multiple Sclerosis Unit, Don C. Gnocchi Foundation, IRCCS, Milan, Italy
JC virus (JCV), the causative agent of progressive multifocal leukoencephalopathy (PML), has been proposed as a possible aetiopathogenic factor in multiple sclerosis (MS). We performed a study to search the LT region of JCV genome by nested PCR in cerebrospinal fluid (CSF), peripheral blood mononuclear cell (PBMC) and urine samples collected from 121 MS patients, 24 patients with other neurological disorders (OND), 30 non neurological patients (NND) and in PBMCs and urine of 40 healthy subjects. JCV DNA has been found in the CSF of 11 MS patients (9%) while all the CSFs from the 24 OND and the 30 NND cases were negative. No significant differences have been observed as regard to the frequency of JCV DNA detection in PBMCs and urine between the MS patients and the control groups. Nucleotide sequences analysis of seven JCV CSF isolates showed that five strains were identical the prototypal strain, while the other two had a base mutation (T C) in 4286 nucleotide (nt). The finding of JCV DNA in the CSF of MS patients suggest that JCV could play a role in the triggering and/or in the maintenance of MS aetiopathogenic process, and therefore it should be taken in consideration when monitoring this disease.
Key Words: JC virus multiple sclerosis cerebrospinal fluid peripheral blood urine polymerase chain reaction
Multiple Sclerosis, Vol. 4, No. 2,
49-54 (1998)
DOI: 10.1177/135245859800400202

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E Iacobaeus, C Ryschkewitsch, M Gravell, M Khademi, E Wallstrom, T Olsson, L Brundin, and E. Major
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
Multiple Sclerosis,
January 1, 2009;
15(1):
28 - 35.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bonig, A. Wundes, and T. Papayannopoulou
Response: More about multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors
Blood,
July 1, 2008;
112(1):
209 - 210.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alvarez-Lafuente, M. Garcia-Montojo, V. De Las Heras, M. Bartolome, and R. Arroyo
JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event
Multiple Sclerosis,
June 1, 2007;
13(5):
590 - 595.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Khalili, M. K. White, F. Lublin, P. Ferrante, and J. R. Berger
Reactivation of JC virus and development of PML in patients with multiple sclerosis
Neurology,
March 27, 2007;
68(13):
985 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Franciotta, A. Bestetti, R. Bergamaschi, G. Piccolo, A. Persico, and P. Cinque
Letter to the Editor
Multiple Sclerosis,
September 1, 2006;
12(5):
674 - 675.
[PDF]
|
 |
|

|
 |

|
 |
 
K Khalili and M K White
Human demyelinating disease and the polyomavirus JCV
Multiple Sclerosis,
April 1, 2006;
12(2):
133 - 142.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nath, A. Venkataramana, D. S. Reich, I. Cortese, and E. O. Major
Progression of progressive multifocal leukoencephalopathy despite treatment with {beta}-interferon
Neurology,
January 10, 2006;
66(1):
149 - 150.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?
Blood,
February 1, 2002;
99(3):
768 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dolei, V. Pietropaolo, E. Gomes, C. Di Taranto, M. Ziccheddu, M. A. Spanu, C. Lavorino, M. Manca, and A. M. Degener
Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre
J. Gen. Virol.,
August 1, 2000;
81(8):
1967 - 1973.
[Abstract]
[Full Text]
|
 |
|
|
|